ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,058Medicare Part D Prescriptions Filled, Including Refills

Rank: 333 out of 1677

$408K Total Retail Price of All Prescriptions

Rank: 504 out of 1677

860 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 860 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 860 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,615 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
HYDROCODONE-ACETAMINOPHEN 400 283 S3 1 4
AMLODIPINE BESYLATE 328 261 2 2
LISINOPRIL 317 223 3 3
SIMVASTATIN 300 233 4 1
CARVEDILOL 247 195 5 20
OMEPRAZOLE 235 180 6 6
LEVOTHYROXINE SODIUM 229 205 7 5
METFORMIN HCL 214 159 8 7
FUROSEMIDE 212 180 9 8
POTASSIUM CHLORIDE 205 185 10 14
PRAVASTATIN SODIUM 188 158 11 10
WARFARIN SODIUM 171 131 12 24
PREDNISONE 165 120 13 40
GLIMEPIRIDE 142 106 14 33
GABAPENTIN 137 103 15 11
CLOPIDOGREL 134 98 16 32
TRAMADOL HCL 129 90 17 16
MELOXICAM 127 76 18 27
CITALOPRAM HBR 120 90 19 22
ATORVASTATIN CALCIUM 113 93 20 13
ALLOPURINOL 110 107 21 31
LOSARTAN POTASSIUM 100 91 22 25
METOPROLOL SUCCINATE 97 91 23 23
CHLORTHALIDONE 96 84 24 137
HYDROCHLOROTHIAZIDE 95 73 25 9
METOPROLOL TARTRATE 86 60 26 12
NEXIUM 82 48 27 19
PANTOPRAZOLE SODIUM 81 72 28 46
TAMSULOSIN HCL 78 78 29 34
ZOLPIDEM TARTRATE 77 59 30 15
FAMOTIDINE 74 50 31 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 60 32 17
BENAZEPRIL HCL 70 53 33 53
DIOVAN 70 66 33 45
FLUTICASONE PROPIONATE 69 41 35 29
AMLODIPINE BESYLATE-BENAZEPRIL 67 47 36 59
TRAZODONE HCL 67 29 36 37
INDOMETHACIN 67 52 R 36 268
CEFDINIR 66 48 39 225
ATENOLOL 63 47 40 21
CRESTOR 61 47 41 28
CYMBALTA 60 29 42 58
SPIRONOLACTONE 56 38 43 88
POLYETHYLENE GLYCOL 3350 56 33 43 76
LOSARTAN-HYDROCHLOROTHIAZIDE 55 48 45 42
SERTRALINE HCL 54 39 46 26
DONEPEZIL HCL 52 48 47 30
METHOCARBAMOL 52 34 R 47 169
ISOSORBIDE MONONITRATE ER 51 35 49 73
CIPROFLOXACIN HCL 50 38 50 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.